2026-07-01 · ANDA212972
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
Official FDA dataset
Drugs@FDA peptide applications
110 selected application records across 36 source years. Each entry is built only from an exact application identifier, approved-original-submission code and date, and reviewed active-ingredient mapping.
1,094Dated AP submissions
1,116Action assignments
1,317Official documents
22Mapped profiles
Newest source dates
Application records
Open selected original record →
2026-06-15 · ANDA213155
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2026-04-29 · BLA761412
Insulin glargine-aldy
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2026-03-30 · ANDA212552
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2026-03-11 · ANDA215245
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2026-02-24 · ANDA217063
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2026-02-24 · ANDA217234
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2026-01-14 · ANDA217590
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-12-22 · NDA218316
Semaglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-12-12 · ANDA213641
Teriparatide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-12-12 · ANDA216589
Octreotide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-11-13 · ANDA215826
Leuprolide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-09-15 · ANDA218813
Glucagon
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-08-27 · ANDA214568
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-07-22 · ANDA214457
Glucagon
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-07-22 · ANDA215421
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-06-09 · ANDA217437
Leuprolide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2025-04-02 · ANDA218115
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2024-12-23 · ANDA215503
Liraglutide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2024-12-12 · ANDA204468
Glucagon
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2024-11-19 · ANDA206697
Exenatide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2024-10-17 · ANDA217957
Leuprolide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2024-09-27 · NDA213224
Octreotide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2024-06-04 · NDA218771
Teriparatide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2024-05-21 · ANDA217193
Lanreotide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2024-05-02 · ANDA217860
Octreotide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2023-12-05 · ANDA210317
Octreotide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2023-11-16 · ANDA208569
Teriparatide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2023-11-16 · ANDA211097
Teriparatide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2023-11-08 · NDA217806
Tirzepatide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2023-06-22 · ANDA216839
Octreotide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2023-06-13 · ANDA216807
Octreotide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2023-02-07 · ANDA209611
Linaclotide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2022-10-28 · ANDA215336
Leuprolide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2022-06-06 · ANDA212963
Leuprolide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →
2022-05-13 · NDA215866
Tirzepatide
Original submission 1 · status AP in the cited dataset.
Open full application timeline →Open selected original record →